Proove Genomics Perseveres with Relaunch, Cementing Their Leadership in Personalized and Predictive Pain Diagnostics

Brian Meshkin, the Health technology executive and award-winning social entrepreneur, has relaunched Proove Genomics, continuing the mission to provide personalized and predictive pain management solutions to Americans in need. Equipped with advanced genetic and information technology tools, and backed by the world's largest clinical-genetic data bank for pain and orthopedics—comprising over 153,000 patients and 28 billion data points—Proove Genomics enables patients and physicians to move beyond subjective pain assessments and "trial-and-error" treatments. Instead, they offer individualized assessments and diagnostics that accurately evaluate pain management and treatment risks. Today marks the "comeback story" for pain patients, the clinicians who treat them, and the personalized medicine laboratory that supports optimal pain management decisions.

LEARN MORE